Showing results (621-630 of 1,274) with videos related to

Sort By:
Pageof 128
Veterinary and Comparative Oncology|August 16, 2026
Immunohistochemical Characterisation of Mismatch Repair Proteins in Feline Cancers: A Pilot Study Using Validated Cross-Reactive AntibodiesShoma Nishibori, Masashi Sakurai, Yumiko Kagawa, et al.
Veterinary and Comparative Oncology|August 22, 2026
Clinical Behaviour and Outcome of Pelvic Osteosarcoma in Dogs: A Retrospective Multicentre Analysis of 74 Cases (2007-2025)Csilla Fejös, Felicitas Czichon, Maureen Griffin, et al.
Veterinary and Comparative Oncology|February 10, 2011
CHOP chemotherapy for the treatment of canine multicentric T-cell lymphomaR B Rebhun, M S Kent, S A E B Borrofka, et al.
Veterinary and Comparative Oncology|November 11, 2010
Oligodendroglial gliomatosis cerebri in a poodleA Galán, S Guil-Luna, Y Millán, et al.
Veterinary and Comparative Oncology|November 11, 2010
Haemoglobin in normal and neoplastic canine mammary glandsS-C Chang, H-F Chen, M-H Chou, et al.
Veterinary and Comparative Oncology|June 29, 2010
Phase II open-label study of single-agent hydroxyurea for treatment of mast cell tumours in dogsK M Rassnick, R Al-Sarraf, D B Bailey, et al.
Veterinary and Comparative Oncology|February 19, 2009
Thyroid transcription factor-1 immunohistochemistry: diagnostic tool and malignancy marker in canine malignant lung tumoursG Bettini, L Marconato, M Morini, et al.
Veterinary and Comparative Oncology|February 19, 2009
A retrospective analysis of radiation therapy for the treatment of feline vaccine-associated sarcomaC Eckstein, F Guscetti, M Roos, et al.
Veterinary and Comparative Oncology|February 19, 2009
Evaluation of dexamethasone as a chemoprotectant for CCNU-induced bone marrow suppression in dogsJ L Intile, K M Rassnick, D B Bailey, et al.
Pageof 128